ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

0R34 Johnson & Johnson

158.50
0.00 (0.00%)
Mar 28 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Johnson & Johnson 0R34 London Ordinary Share
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 158.50 08:40:30
Open Price Low Price High Price Close Price Previous Close
158.50 158.50
more quote information »

Recent News

Date Time Source Heading
3/25/202413:28ALNCNewsIN BRIEF: J&J submits US premarket approval application for..
3/18/202406:10ALNCNewsIN BRIEF: Johnson & Johnson receives FDA recommendation for..
2/23/202412:32ALNCNewsIN BRIEF: Johnson & Johnson gets EMA nod for Carvykti in..
2/02/202400:22ALNCNewsTOP NEWS: US sends drugmakers initial offers in Medicare..
1/23/202405:41ALNCNewsTOP NEWS: Johnson & Johnson eyes future growth; 2023 sales..
1/19/202415:34ALNCNewsIN BRIEF: J&J gets US FDA approval for cancer treatment..
12/05/202307:24ALNCNewsTOP NEWS: J&J expects strong long-term growth in three key..
10/23/202306:03ALNCNewsJ&J report slew of positive trial results focused on various..
10/17/202305:46ALNCNewsTOP NEWS: J&J raises full-year sales outlook after "solid"..
10/06/202310:52ALNCNewsIN BRIEF: J&J applies for indication extension to EMA for..
10/03/202311:00ALNCNewsDrugmakers agree to US government price talks amid pushback
9/07/202300:50ALNCNewsJ&J's Janssen ends Phase 3 MACiTEPH study evaluating..
8/30/202311:07ALNCNewsTOP NEWS: J&J forecasts strong growth in earnings after..
8/10/202315:34ALNCNewsIN BRIEF: Johnson & Johnson's blood cancer therapy approved..
7/20/202306:30ALNCNewsTOP NEWS: J&J ups full-year guidance after "robust" second..
5/30/202310:48ALNCNewsJ&J seeks FDA approval for pulmonary arterial hypertension..
5/09/202314:23ALNCNewsJ&J says Tremfya data shows positive results for ulcerative..
5/04/202306:41ALNCNewsIN BRIEF: J&J prices subsidiary Kenvue's NYSE initial public..
5/01/202301:51ALNCNewsJohnson & Johnson reports first results from TAR-200 study
4/18/202306:06ALNCNewsTOP NEWS: J&J swings to first quarter loss due to litigation..
4/05/202300:01ALNCNewsJ&J proposes USD8.9 billion settlement of talc cancer claims
4/04/202315:57ALNCNewsIN BRIEF: J&J subsidiary re-files for bankruptcy amid talc..

Your Recent History

Delayed Upgrade Clock